The Drug That’s Getting a Second Chance: Thioridazine and Cancer Stem Cells
Even when still available, Thioridazine was anything but a first-line drug in treating psychosis or schizophrenia–and that was before it was withdrawn from the market. In the class of the first-generation or ‘typical’ antipsychotics, its main purpose was to treat… Continue Reading